{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:11:50Z","timestamp":1763140310554},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T00:00:00Z","timestamp":1205366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Morphine withdrawal leads to an increase in corticosterone concentration in plasma, and cognitive deficits are found after withdrawal. Evidence indicates that glucocorticoid hormones affect memory. The aim of the current study was to evaluate the effects of metyrapone and mifepristone on memory deficit following spontaneous morphine withdrawal. Memory was tested by using the object recognition task. The novel object recognition task was carried out in a square wooden open\u2010field apparatus using objects. The test was comprised of three sections: habituation for 15\u00a0min., first trial for 12\u00a0min. and test trial for 5\u00a0min. In this learning paradigm, the difference in exploration between a previously seen object and a novel object is taken as an index of memory performance (recognition index \u2013 RI). Male mice were made dependent by increasing doses of morphine (30\u201390\u00a0mg\/kg) subcutaneously twice daily for 3 days. RI was assessed 4\u00a0hr after the last dose of morphine on the third day. Mifepristone (50 and 100\u00a0mg\/kg) and metyrapone (12.5 and 25\u00a0mg\/kg) were used subcutaneously before the first trial and effects were compared to control values. Metyrapone (25\u00a0mg\/kg) and mifepristone (50\u00a0mg\/kg) improved RI to 34.8\u00a0\u00b1\u00a010.8% and 25.4\u00a0\u00b1\u00a011.7%, respectively, which are significantly different from control values (RI\u00a0=\u00a0\u221214.8\u00a0\u00b1\u00a010.7%, P\u00a0&lt;\u00a00.05). These results show that increased glucocorticoid concentration may be involved in memory deficit caused by morphine withdrawal. Metyrapone by inhibiting glucocorticoid formation, and mifepristone by inhibiting glucocorticoid receptors may be useful for preventing memory deficit following morphine withdrawal.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2007.00183.x","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T15:39:08Z","timestamp":1205422748000},"page":"377-381","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metyrapone and Mifepristone Reverse Recognition Memory Loss Induced by Spontaneous Morphine Withdrawal in Mice"],"prefix":"10.1111","volume":"102","author":[{"given":"Azadeh","family":"Mesripour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valiollah","family":"Hajhashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(98)00030-4"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952999509095229"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(85)90017-0"},{"key":"e_1_2_6_5_2","first-page":"607","volume-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","author":"O\u2019Brian CP","year":"2006"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(81)90172-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000087034"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1641-04.2004"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(01)00018-8"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(97)00004-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2005.03.005"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-4388(02)00306-9"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/nlme.2002.4080"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.09.015"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2005.06.010"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(90)90250-L"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-1047(82)91020-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000163509.27577.DA"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(88)90157-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2006.04.001"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(01)00277-9"},{"key":"e_1_2_6_22_2","first-page":"171","article-title":"Effects of Otostegia persica (Burm.) Boiss on morphine withdrawal syndrome in mice","volume":"3","author":"Hajhashemi V","year":"2004","journal-title":"Iran J Pharmceut Res"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1101\/lm.61704"},{"key":"e_1_2_6_24_2","first-page":"103","article-title":"Effects of tamoxifen, mifepristone and cyproterone on the electroconvulsive threshold and pentetrazole\u2010induced convulsions in mice","volume":"54","author":"Borowicz KK","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20042023"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307803100"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(03)00117-7"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199703240-00023"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(96)00028-5"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0406344101"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.5.1162"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)02078-0"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2007.02.038"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2007.00183.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2007.00183.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:03:54Z","timestamp":1697058234000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2007.00183.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,13]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1742-7843.2007.00183.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2007.00183.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,13]]},"assertion":[{"value":"2008-03-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}